Objectives: To evaluate the effectiveness of extended-release quetiapine fumarate
(quetiapine XR) as once-daily monotherapy for bipolar depression. Method: Patients in this …

Abstract Background and purpose: Banxia-Houpo-Tang (Banha-Hubak-Tang, BHT) is an
East Asian traditional herbal medicine used for treating depression. Hence, this review …

Objective: To evaluate the efficacy, safety, and tolerability of adjunctive osmotic-release oral
system (OROS) methylphenidate in outpatients with major depressive disorder (MDD) …

IntroductionBuprenorphine/samidorphan (BUP/SAM), a combination of BUP (a µ-opioid
receptor partial agonist and κ-antagonist) and SAM (a sublingually bioavailable µ-opioid …

Morita therapy is a systematic psychological therapy that aims to improve everyday
functioning rather than target specific symptoms. However, there has been no systematic …

Background Altered neurotransmission of γ-aminobutyric acid (GABA) has been implicated
in the pathogenesis of depression. Whether SAGE-217, an oral, positive allosteric modulator …

In a double-blind, placebo controlled clinical trial, the efficacy and tolerance of 8 weeks'
treatment with Neurapas® tablets for moderate to severe depressive symptoms was …

Objective: In a phase 3 randomized double-blind placebo-controlled study, the authors
investigated the efficacy and safety of 42 mg/day of lumateperone in patients with bipolar I or …

Aim: To evaluate the efficacy and tolerability of once-daily quetiapine XR (extended release)
monotherapy in patients with MDD (unipolar depression) compared with placebo. Methods …

BACKGROUND: To evaluate the effectiveness of quetiapine extended release once daily in
bipolar depression. METHODS: Double-blind, placebo-controlled study in acutely …